1. KRAS status and efficacy in the firstline treatment of patients with metastatic colorectal cancer treated with FOLFIRI with or without cetuximab: The CRYSTAL experience;Van Cutsem;J Clin Oncol,2008
2. KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer with FOLFOX with or without cetuximab: The OPUS experience;Bokemeyer;J Clin Oncol,2008
3. Cetuximab plus 5-FU/FA/oxaliplaint (FOLFOX-4) versus FOLFOX-4 in the first-line treatment of metastatic colorectal cancer (mCRC): OPUS, a randomized phase II study;Bokeymeyer;J Clin Oncol,2007
4. Randomized phase III study of capecitabine, oxaliplatin, and bevacizuamb with or without cetuximab in advanced colorectal cancer (ACC), the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG);Punt;J Clin Oncol,2008